Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy

ABSTRACT: Objective: The malignant spread of histologically benign struma ovarii was historically referred to as peritoneal strumosis. Recently, highly differentiated follicular carcinoma of ovarian origin (HDFCO) was proposed as a more accurate diagnostic term for this rare disease. We report the u...

Full description

Bibliographic Details
Main Authors: Natalie M. Liu, BS, Neda Moatamed, MD, Racquel S. Bueno, MD, Wendy L. Sacks, MD
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:AACE Clinical Case Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2376060520301899
id doaj-8c629082f12345f8b1066641bc4bf4fb
record_format Article
spelling doaj-8c629082f12345f8b1066641bc4bf4fb2021-04-30T07:23:53ZengElsevierAACE Clinical Case Reports2376-06052017-01-0133e264e268Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral OophorectomyNatalie M. Liu, BS0Neda Moatamed, MD1Racquel S. Bueno, MD2Wendy L. Sacks, MD3From the 1Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CaliforniaFrom the 1Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CaliforniaDepartment of Surgery, Ekahi Central Medical Center, Honolulu, HawaiiDepartment of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.; Address correspondence to Dr. Wendy L. Sacks, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA 90048.ABSTRACT: Objective: The malignant spread of histologically benign struma ovarii was historically referred to as peritoneal strumosis. Recently, highly differentiated follicular carcinoma of ovarian origin (HDFCO) was proposed as a more accurate diagnostic term for this rare disease. We report the unusual case presentation of a woman with HDFCO and the subsequent management of her cancer.Methods: Her interventions included abdominal surgery, postoperative laboratory tests, imaging, thyroidectomy, radioactive iodine-123 (RAI-123) diagnostic screening, and thyroid function studies.Results: A 72-year-old Chinese female was diagnosed with metastatic HDFCO approximately 30 years after hysterectomy and bilateral oophorectomy. While undergoing evaluation for an upper gastrointestinal bleed, a computed tomography scan revealed a 10 cm pelvic mass and multiple other peritoneal tumors. She underwent tumor debulking surgery, and the pathology was interpreted at two institutions; both made the diagnosis of a very well-differentiated follicular carcinoma arising in struma ovarii. Lab tests revealed hyperthyroidism and RAI-123 uptake confirmed tumor production of thyroid hormone. A total thyroidectomy was performed in anticipation of treatment with radioactive iodine-131 (RAI-131). However, the patient remained clinically asymptomatic and, therefore, neither additional tumor debulking nor RAI-131 treatment were performed. No disease progression has been noted for over 3 years.Conclusion: This case highlights the potentially slow-growing nature of HDFCO which, in such cases, may be suited to less aggressive disease management.Abbreviations: CT computed tomography; Hb hemoglobin; HDFCO highly differentiated follicular carcinoma of ovarian origin; RAI-123 radioactive iodine-123; RAI-131 radioactive iodine-131; T3 triiodothyronine; T4 thyroxine; TSH thyroid-stimulating hormone;http://www.sciencedirect.com/science/article/pii/S2376060520301899
collection DOAJ
language English
format Article
sources DOAJ
author Natalie M. Liu, BS
Neda Moatamed, MD
Racquel S. Bueno, MD
Wendy L. Sacks, MD
spellingShingle Natalie M. Liu, BS
Neda Moatamed, MD
Racquel S. Bueno, MD
Wendy L. Sacks, MD
Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy
AACE Clinical Case Reports
author_facet Natalie M. Liu, BS
Neda Moatamed, MD
Racquel S. Bueno, MD
Wendy L. Sacks, MD
author_sort Natalie M. Liu, BS
title Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy
title_short Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy
title_full Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy
title_fullStr Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy
title_full_unstemmed Proliferative Highly Differentiated Follicular Carcinoma Of Ovarian Origin (Hdfco) Presenting Long After Bilateral Oophorectomy
title_sort proliferative highly differentiated follicular carcinoma of ovarian origin (hdfco) presenting long after bilateral oophorectomy
publisher Elsevier
series AACE Clinical Case Reports
issn 2376-0605
publishDate 2017-01-01
description ABSTRACT: Objective: The malignant spread of histologically benign struma ovarii was historically referred to as peritoneal strumosis. Recently, highly differentiated follicular carcinoma of ovarian origin (HDFCO) was proposed as a more accurate diagnostic term for this rare disease. We report the unusual case presentation of a woman with HDFCO and the subsequent management of her cancer.Methods: Her interventions included abdominal surgery, postoperative laboratory tests, imaging, thyroidectomy, radioactive iodine-123 (RAI-123) diagnostic screening, and thyroid function studies.Results: A 72-year-old Chinese female was diagnosed with metastatic HDFCO approximately 30 years after hysterectomy and bilateral oophorectomy. While undergoing evaluation for an upper gastrointestinal bleed, a computed tomography scan revealed a 10 cm pelvic mass and multiple other peritoneal tumors. She underwent tumor debulking surgery, and the pathology was interpreted at two institutions; both made the diagnosis of a very well-differentiated follicular carcinoma arising in struma ovarii. Lab tests revealed hyperthyroidism and RAI-123 uptake confirmed tumor production of thyroid hormone. A total thyroidectomy was performed in anticipation of treatment with radioactive iodine-131 (RAI-131). However, the patient remained clinically asymptomatic and, therefore, neither additional tumor debulking nor RAI-131 treatment were performed. No disease progression has been noted for over 3 years.Conclusion: This case highlights the potentially slow-growing nature of HDFCO which, in such cases, may be suited to less aggressive disease management.Abbreviations: CT computed tomography; Hb hemoglobin; HDFCO highly differentiated follicular carcinoma of ovarian origin; RAI-123 radioactive iodine-123; RAI-131 radioactive iodine-131; T3 triiodothyronine; T4 thyroxine; TSH thyroid-stimulating hormone;
url http://www.sciencedirect.com/science/article/pii/S2376060520301899
work_keys_str_mv AT nataliemliubs proliferativehighlydifferentiatedfollicularcarcinomaofovarianoriginhdfcopresentinglongafterbilateraloophorectomy
AT nedamoatamedmd proliferativehighlydifferentiatedfollicularcarcinomaofovarianoriginhdfcopresentinglongafterbilateraloophorectomy
AT racquelsbuenomd proliferativehighlydifferentiatedfollicularcarcinomaofovarianoriginhdfcopresentinglongafterbilateraloophorectomy
AT wendylsacksmd proliferativehighlydifferentiatedfollicularcarcinomaofovarianoriginhdfcopresentinglongafterbilateraloophorectomy
_version_ 1721498493700276224